LivaNova PLC (LIVN)
LivaNova PLC (LIVN) from its SEC filings: 2025 revenue $1.4 billion (+11% vs the year before), net margin -18%, free cash flow $173.3 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Revenue (2025) | $1.4 billion |
| Revenue growth | +11% |
| Net income | -$242.5 million |
| Net margin | -17.5% |
| Free cash flow | $173.3 million |
| Diluted EPS | $-4.45 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +11% |
| Cash | $516.6 million |
| Long-term debt | $289.9 million |
| Share count, 1 year | +1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.